EX-FILING FEES 3 d845792dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-1

(Form Type)

Plus Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities

 

                 
    

Security

Type

 

Security

Class Title

 

Fee

Calculation

or Carry

Forward

Rule

 

Amount

Registered

 

Proposed

Maximum

Offering

Price Per

Unit

 

Maximum

Aggregate

Offering

Price(1)

 

Fee

Rate

 

Amount of

Registration
Fee(2)

                 

Fees Previously

Paid

  Equity   Common Stock, $0.0001 par value per share(2)(3)   457(o)       $8,000,000.00   $0.00014760   $1,180.80
                 
    Other   Warrants to purchase Common Stock(4)   457(g)           $0.00
                 

Fees to Be

Paid

  Equity   Common Stock issuable upon exercise of Warrants to purchase Common Stock(2)   457(o)       $8,000,000.00   $0.00014760   $1,180.80
                 
    Other   Pre-Funded Warrants to purchase Common Stock(3)(4)   457(g)           $0.00
                 
    Equity   Common Stock issuable upon exercise of the Pre-Funded Warrants(2)(3)  

457(o)

          $0.00
                 
   

Other

  Placement Agent Warrants to purchase Common Stock(4)   457(g)           $0.00
                 

Fees to Be

Paid

  Equity   Common Stock issuable upon exercise of the Placement Agent Warrants(2)   457(o)         $0.00014760    
           
    Total Offering Amounts      $16,000,000.00   $0.00014760   $2,361.60
           
    Total Fees Previously Paid(5)         

$2,352.38

           
    Total Fee Offsets         
           
    Net Fee Due                $9.22

 

(1)

Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

 

(2)

Pursuant to Rule 416 under the Securities Act, the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting from stock splits, dividends or similar transactions.

 

(3)

The proposed maximum aggregate offering price of the common stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $8,000,000.00.

 

(4)

Pursuant to Rule 457(g) under the Securities Act, no separate registration fee is required for the warrants because the warrants are being registered in the same registration statement as the common stock issuable upon exercise of such warrants.

 

(5)

The Registrant previously paid a filing fee of $2,352.38 in connection with the initial filing of this Registration Statement on Form S-1 on November 22, 2023.